Profile: Innocoll, Inc. is a specialty pharmaceutical and drug delivery company engaged in the research and manufacture of collagen-based technologies for local drug delivery, surgical implants, advanced wound care and oncology. Our collagen based medical products utilize the company's drug delivery technology platforms CollaRx® and LiquiColl®. These technologies are fully biodegradable and designed for the localized, site-specific delivery of a wide variety of drugs and are specifically intended to minimize systemic exposure and associated side effects.

The company has revenues of USD 5-10 Million, has ~30 employees.